-
CONCEPTUAL COST-EFFECTIVENESS FRAMEWORK FOR GMRX2 (TELMISARTAN/AMLODIPINE/INDAPAMIDE) AS EARLY COMBINATION THERAPY FOR US ADULTS WITH HYPERTENSION WITHOUT MAJOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, USED EITHER AT INITIATION OR AS A STEP-UP FROM...
Mar 18, 2026, 21:38 PM -
PERSONALITY PROFILES AND BURNOUT DIMENSIONS AMONG EMERGENCY CARE PROFESSIONALS IN HUNGARY: A CROSS-SECTIONAL STUDY
Mar 18, 2026, 21:38 PM -
CLINICAL TRIAL EVIDENCE SUPPORTING FDA APPROVAL OF NOVEL AGENTS IN 2024
Mar 18, 2026, 21:38 PM -
THE POTENTIAL EARLY IMPACT OF THE INFLATION REDUCTION ACT ON BUY-SIDE VALUATION METHODOLOGIES AND TRANSACTION STRUCTURING IN THE PHARMACEUTICAL INDUSTRY
Mar 18, 2026, 21:38 PM -
DISTINGUISHING AI FROM AUTOMATION IN HEOR: LESSONS FROM OTHER INDUSTRIES
Mar 18, 2026, 21:38 PM -
THE PRICE OF FEAR: VALUING FEAR OF CONTAGION FOR VACCINE ECONOMIC APPRAISAL: A TARGETED REVIEW
Mar 18, 2026, 21:38 PM -
ECONOMIC AND EPIDEMIOLOGICAL BURDEN OF DIABETES IN MAGHREB COUNTRIES: ALGERIA, TUNISIA, AND MOROCCO
Mar 18, 2026, 21:38 PM -
UNDERSTANDING STAKEHOLDER PERSPECTIVES BETWEEN ENDOVASCULAR AND HYBRID REPAIR FOR THORACIC AORTIC ANEURYSMS AND DISSECTIONS INVOLVING THE LEFT SUBCLAVIAN ARTERY
Mar 18, 2026, 21:38 PM -
BRIDGING HER2 TESTING AND TREATMENT: REAL-WORLD EVIDENCE ACROSS 22 SOLID TUMORS
Mar 18, 2026, 21:38 PM -
MAPPING THE BURDEN AND MANAGEMENT OF ASTHMA, SEVERE ASTHMA, AND EOSINOPHILIC ASTHMA ACROSS ONTARIO, CANADA
Mar 18, 2026, 21:38 PM -
COMPARING THECOSTEFFECTIVENESS OFONSITEBUPRENORPHINE TREATMENT VERSUSTREATMENT FACILITY REFERRALATHARM REDUCTION AGENCIES
Mar 18, 2026, 21:38 PM -
PSYCHOMETRIC VALIDATION OF THE QLQ-AA/PNH-54 BASED ON A POOLED DATASET OF A CLINICAL TRIAL AND TWO REAL-WORLD STUDIES OF CROVALIMAB IN PARTICIPANTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Mar 18, 2026, 21:38 PM -
NEUROLOGIST PREFERENCES FOR NEW MS TREATMENTS: IMPLICATIONS FOR MARKET ACCESS PRIORITIZATION IN THE UNITED STATES AND EUROPE
Mar 18, 2026, 21:38 PM -
INCREASING UTILITY OF INTEGRATED REAL-WORLD EVIDENCE THROUGHOUT THE PRODUCT LIFECYCLE TO SUPPORT HEALTHCARE REIMBURSEMENT
Mar 18, 2026, 21:38 PM -
ADVANCING EQUITY IN PROSTATE CANCER RESEARCH: STRATEGY AND OUTCOMES FROM A PROSPECTIVE ENROLLMENT INITIATIVE
Mar 18, 2026, 21:38 PM -
HETEROGENEOUS RESPONSES TO BRAZIL’S PHARMACEUTICAL PRICE CAP REGULATION: EVIDENCE FROM PRIVATE INSURANCES AND THE UNIFIED HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
FORMULARY EXCLUSIONS AND NON-ADHERENCE TO DISEASE-MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS IN MEDICARE PART D
Mar 18, 2026, 21:38 PM -
ROLE OF REAL-WORLD EVIDENCE IN SUPPORTING AND VALIDATING CROSSOVER ADJUSTMENTS OF OVERALL SURVIVAL IN ONCOLOGY TRIALS: A SYSTEMATIC LITERATURE REVIEW OF HEALTH TECHNOLOGY ASSESSMENTS OF TREATMENTS FOR SELECTED TUMORS
Mar 18, 2026, 21:38 PM -
COST ANALYSIS OF WHOLE-BODY PET-CT SCAN USING TIME-DRIVEN ACTIVITY-BASED COSTING AT A GOVERNMENT CANCER HOSPITAL IN NORTH INDIA
Mar 18, 2026, 21:38 PM -
ASSESSING THE VALUE OF LOST SCHOOLING DUE TO ILLNESS AMONG CHILDREN IN THE UNITED STATES
Mar 18, 2026, 21:38 PM
